MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 18 filers reported holding MYRIAD GENETICS INC in Q1 2013. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2016 | $212,000 | -22.9% | 6,939 | -5.5% | 0.02% | -15.8% |
Q1 2016 | $275,000 | -41.6% | 7,339 | -32.7% | 0.02% | -50.0% |
Q4 2015 | $471,000 | +0.9% | 10,904 | -12.4% | 0.04% | +2.7% |
Q3 2015 | $467,000 | +10.4% | 12,450 | 0.0% | 0.04% | +27.6% |
Q2 2015 | $423,000 | -2.8% | 12,450 | +1.3% | 0.03% | -3.3% |
Q1 2015 | $435,000 | +2.6% | 12,294 | -1.3% | 0.03% | +3.4% |
Q4 2014 | $424,000 | -11.7% | 12,450 | 0.0% | 0.03% | -17.1% |
Q3 2014 | $480,000 | -23.2% | 12,450 | -22.4% | 0.04% | -16.7% |
Q2 2014 | $625,000 | +13.8% | 16,050 | 0.0% | 0.04% | +20.0% |
Q1 2014 | $549,000 | +37.2% | 16,050 | -15.9% | 0.04% | +29.6% |
Q4 2013 | $400,000 | -1.0% | 19,080 | +11.1% | 0.03% | -22.9% |
Q3 2013 | $404,000 | -15.1% | 17,180 | -3.1% | 0.04% | -28.6% |
Q2 2013 | $476,000 | +7.4% | 17,730 | +1.7% | 0.05% | +4.3% |
Q1 2013 | $443,000 | – | 17,440 | – | 0.05% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SCOPIA CAPITAL MANAGEMENT LP | 6,459,139 | $278,776,000 | 5.53% |
Tieton Capital Management, LLC | 119,290 | $5,149,000 | 4.04% |
RPg Family Wealth Advisory, LLC | 97,202 | $4,195,238,000 | 3.85% |
RK Capital | 384,900 | $16,612,000 | 2.90% |
Contrarius Investment Management Ltd | 652,288 | $28,153,000 | 2.65% |
S&T BANK/PA | 331,885 | $14,324,000 | 2.22% |
Euclidean Technologies Management, LLC | 40,917 | $1,766,000 | 1.90% |
AIMZ Investment Advisors, LLC | 45,635 | $1,970,000 | 1.80% |
Taylor Frigon Capital Management LLC | 34,783 | $1,486,000 | 1.67% |
KILLEN GROUP INC | 366,305 | $15,810,000 | 1.63% |